Frontispiece: Efficient Inhibition of SARS‐CoV‐2 Using Chimeric Antisense Oligonucleotides through RNase L Activation. Issue 40 (20th September 2021) - Su, Xiaoxuan
Abstract : SARS‐CoV‐2 In their Communication on page 21662, Xinjing Tang et al. report the efficient inhibition of SARS‐CoV‐2 using chimeric antisense oligonucleotides through RNase L activation.